HI
AZN icon

Harbour Investments’s AstraZeneca AZN Stock Holding History

Harbour Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
9,609
-1,265
-12% -$238K 0.02% 578
2026
Q1 		$2.14M Buy
10,874
+5,855
+117% +$1.13M 0.03% 473
2025
Q4 		$923K Sell
5,019
-108
-2% -$18.9K 0.02% 629
2025
Q3 		$787K Buy
5,127
+405
+9% +$61.3K 0.02% 647
2025
Q2 		$660K Sell
4,722
-18
-0.4% -$2.52K 0.02% 670
2025
Q1 		$697K Sell
4,740
-223
-4% -$32.3K 0.02% 606
2024
Q4 		$650K Buy
4,963
+560
+13% +$78.4K 0.02% 619
2024
Q3 		$686K Buy
4,403
+80
+2% +$12.9K 0.02% 560
2024
Q2 		$674K Buy
4,323
+530
+14% +$79.8K 0.02% 523
2024
Q1 		$514K Buy
3,793
+262
+7% +$34.7K 0.02% 584
2023
Q4 		$476K Buy
3,531
+120
+4% +$15.6K 0.02% 548
2023
Q3 		$462K Buy
3,411
+122
+4% +$16.7K 0.02% 509
2023
Q2 		$471K Sell
3,289
-14
-0.4% -$2.06K 0.02% 514
2023
Q1 		$459K Buy
3,303
+182
+6% +$24.5K 0.03% 492
2022
Q4 		$423K Buy
3,121
+125
+4% +$15.7K 0.03% 497
2022
Q3 		$396K Hold
2,996
– – 0.03% 474
2022
Q2 		$396K Buy
+2,996
New +$393K 0.03% 474
2021
Q4 		$106K Sell
913
-6,254
-87% -$736K 0.01% 952
2021
Q3 		$861K Buy
7,167
+2,724
+61% +$317K 0.03% 486
2021
Q2 		$532K Sell
4,443
-204
-4% -$22.4K 0.02% 654
2021
Q1 		$462K Buy
+4,647
New +$467K 0.02% 635

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Harbour Investments's AZN Position: Q2 2026 in Review

Harbour Investments reduced its AstraZeneca (AZN) stake by 12% in Q2 2026, selling an estimated $238K and leaving 9,609 shares worth $1.82M. The position accounts for 0.02% of the portfolio, ranked #578.

Harbour Investments first reported a position in AZN in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.14M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Harbour Investments held 9,609 shares of AstraZeneca worth $1.82M as of Q2 2026.
  • Harbour Investments sold 1,265 AstraZeneca shares in Q2 2026, an estimated $238K.
  • AstraZeneca made up 0.02% of Harbour Investments's portfolio in Q2 2026, its #578 holding.
  • Harbour Investments first reported a position in AstraZeneca in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's AstraZeneca position peaked at $2.14M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.